Literature DB >> 15105545

Yaba-like disease virus protein Y144R, a member of the complement control protein family, is present on enveloped virions that are associated with virus-induced actin tails.

Mansun Law1,2, Michael Hollinshead2, Han-Joo Lee1, Geoffrey L Smith1,2.   

Abstract

Yaba-like disease virus (YLDV) is a yatapoxvirus, a group of slow-growing poxviruses from primates. Analysis of the growth cycle of YLDV in tissue culture showed that maximum virus titres were reached 3 days post-infection and at this time only 3.3 % of infectious progeny was extracellular. The intracellular and extracellular virions have different buoyant densities and are separable on CsCl density gradients. They are also distinguishable by electron microscopy with the extracellular virions having an additional lipid envelope. In YLDV-infected cells, thick actin bundles with virions at their tips were seen protruding from the cell surface, despite the fact that YLDV lacks a protein comparable to Vaccinia virus A36R, which is required for VV-induced actin tail formation. In addition to these observations, the YLDV gene Y144R was characterized. This gene is predicted to encode a transmembrane protein containing three short consensus repeat (SCR) motifs common to members of the complement control protein family. Antibody generated against recombinant Y144R recognized products of 36, 41 and 48-55 kDa in YLDV-infected cells and purified extracellular enveloped virus (EEV) but not intracellular mature virus (IMV). Y144R protein is a glycoprotein with type I membrane topology that is synthesized early and late during infection. By immunoblot, indirect immunofluorescence and immuno-cryoelectron microscopy the Y144R protein was detected on the intracellular enveloped virus (IEV), cell-associated enveloped virus (CEV) and EEV. This represents the first study of a YLDV IEV, CEV and EEV protein at the molecular level.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105545     DOI: 10.1099/vir.0.79863-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Loss of cytoskeletal transport during egress critically attenuates ectromelia virus infection in vivo.

Authors:  Helena Lynn; Jacquelyn Horsington; Lee Kuan Ter; Shuyi Han; Yee Lian Chew; Russell J Diefenbach; Michael Way; Geeta Chaudhri; Gunasegaran Karupiah; Timothy P Newsome
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Vaccinia protein F12 has structural similarity to kinesin light chain and contains a motor binding motif required for virion export.

Authors:  Gareth W Morgan; Michael Hollinshead; Brian J Ferguson; Brendan J Murphy; David C J Carpentier; Geoffrey L Smith
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

Review 3.  Arp2/3-mediated actin-based motility: a tail of pathogen abuse.

Authors:  Matthew D Welch; Michael Way
Journal:  Cell Host Microbe       Date:  2013-09-11       Impact factor: 21.023

4.  Ligand-induced and nonfusogenic dissolution of a viral membrane.

Authors:  Mansun Law; Gemma C Carter; Kim L Roberts; Michael Hollinshead; Geoffrey L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

5.  A new inhibitor of apoptosis from vaccinia virus and eukaryotes.

Authors:  Caroline Gubser; Daniele Bergamaschi; Michael Hollinshead; Xin Lu; Frank J M van Kuppeveld; Geoffrey L Smith
Journal:  PLoS Pathog       Date:  2007-02       Impact factor: 6.823

6.  Loss of Actin-Based Motility Impairs Ectromelia Virus Release In Vitro but Is Not Critical to Spread In Vivo.

Authors:  Melanie Laura Duncan; Jacquelyn Horsington; Preethi Eldi; Zahrah Al Rumaih; Gunasegaran Karupiah; Timothy P Newsome
Journal:  Viruses       Date:  2018-03-05       Impact factor: 5.048

7.  Camelpox virus encodes a schlafen-like protein that affects orthopoxvirus virulence.

Authors:  Caroline Gubser; Rory Goodbody; Andrea Ecker; Gareth Brady; Luke A J O'Neill; Nathalie Jacobs; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2007-06       Impact factor: 3.891

8.  Vaccinia virus egress mediated by virus protein A36 is reliant on the F12 protein.

Authors:  David C J Carpentier; Alexander Van Loggerenberg; Nele M G Dieckmann; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2017-06-20       Impact factor: 3.891

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.